KKR stock: Gentari stake and Integer deal shape weekly focus
Published on 11/21/2026 at 11:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKKR expands portfolio activity
- KKR-backed accounts invested in Gentari's Indian renewables platform on November 19.
- An affiliate of KKR completed the Integer acquisition on November 17, taking the medical-device maker private.
- The Gentari platform has about 8 gigawatts of operating, under-construction and contracted renewable capacity.
KKR expanded its portfolio activity during the week of November 16-20, with a new India renewables investment and the completion of a major medical-device acquisition.
Two portfolio moves in one week
On November 19, KKR-advised capital accounts made a minority investment in Gentari Renewables India, according to Fidelity. Gentari will retain strategic oversight and operational control of the platform. Financial terms were not disclosed.
The Indian business has about 8 gigawatts of operating, under-construction and contracted renewable capacity, spanning solar, wind, hybrid power and battery storage. For KKR, the transaction adds exposure to an infrastructure platform serving commercial, industrial and government customers.
On November 17, an affiliate of KKR investment funds completed the acquisition of Integer Holdings. The transaction carried an enterprise value of about 5.7 billion US dollars, and Integer shareholders received 127 US dollars in cash per share, according to KKR. Integer's common stock ceased trading on the New York Stock Exchange after completion.
Share price and investor context
KKR stock traded at 80.73 euros on Lang & Schwarz at 11:25 CET on Saturday, November 21.
KKR company facts
- Company: KKR & Co. Inc.
- ISIN: US48251W1045
- Primary ticker: KKR
- Primary exchange: New York Stock Exchange
- Latest quoted price: 80.73 euros on Lang & Schwarz, November 21, 2026, 11:25 CET
Market attention around KKR also reflects the broader US equity environment; see Current market reports.
